Trials / Unknown
UnknownNCT05382910
A Study of MG-K10 in Subjects With Asthma
Phase Ib/II Clinical Trial of Safety, Pharmacokinetics and Preliminary Efficacy of MG-K10 Humanized Monoclonal Antibody Injection in Adult Asthmatic Subjects
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- Shanghai Mabgeek Biotech.Co.Ltd · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is a phase Ib/II clinical trial conducted in Chinese adult asthmatic subjects to evaluate the preliminary efficacy and safety of MG-K10 humanized monoclonal antibody injection in the treatment of asthma.
Detailed description
The study was conducted in two phases: the Phase Ib study focused on the safety and tolerability of MG-K10 in adult asthma subjects. Phase II study focused on the preliminary efficacy in adults with moderate to severe asthma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MG-K10 | MG-K10 Humanized Monoclonal Antibody Injection |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2022-07-05
- Primary completion
- 2023-12-20
- Completion
- 2024-06-20
- First posted
- 2022-05-19
- Last updated
- 2023-08-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05382910. Inclusion in this directory is not an endorsement.